SLU-PP-332

A short-acting GLP-1 receptor agonist derived from exendin-4, with a 4-hour half-life in humans, designed for prandial glucose control

A weekly GLP-1 receptor agonist formulated as a fusion protein with human IgG4 Fc domain, which extends its half-life via FcRn recycling

Which promotes intestinal epithelial cell proliferation and reduces intestinal permeability

An amylin analog, a synthetic peptide that mimics the effects of endogenous amylin, a hormone co-secreted with insulin by pancreatic 尾-cells

A synthetic peptide derived from the saliva of the Gila monster (Heloderma suspectum), acting as a GLP-1 receptor agonist with a longer half-life than human GLP-1

A GLP-1 receptor agonist conjugated to human albumin, which extends its half-life to allow once-weekly administration